Treatment for breast cancer during pregnancy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background: The relevance of treating patients diagnosed with breast cancer during pregnancy is indisputable. In recent years, the number of patients has become larger due to increases in the age of pregnant women and in the number of IVF procedures. Case report: The paper describes an observation of a 24-year-old patient at diagnosis; the follow-up of the patient and her child lasted 6 years. The patient received combination chemotherapy cycles during pregnancy, which were followed by delivery, continuation of drug therapy involving chemotherapy and targeted therapy cycles and by surgical treatment. The patient having a VRCA1 gene mutation underwent preventive subcutaneous mastectomy with simultaneous reconstruction for mutation carriage; thus, bilateral breast reconstruction surgery that is a method of surgical rehabilitation was performed. Conclusion: An ultrasound study of the breasts is a mandatory diagnostic technique during pregnancy; if any breast nodule is present, its morphological verification is needed.

Full Text

Restricted Access

About the authors

Elena A. Rasskazova

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: rasskaz2@yndex.ru
PhD, Researcher of the Department of Oncology and Reconstructive Surgery of the Mammary Gland and Skin

Aziz D. Zikiryakhodzhaev

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia

Email: azizz@mail.ru
Dr. Med. Sci., Head of the Department of Oncology and Reconstructive Surgery of the Mammary Gland and Skin

Andrey D. Kaprin

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia; Peoples' Friendship University of Russia

Dr. Med. Sci., Professor, Academician of RAS, Academician of RAE, Honored Doctor of the Russian Federation, CEO, National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Director; Head of the Department of Urology and Operative Nephrology with the Course of Oncourology, Faculty of Medicine

References

  1. Параконная А.А. Рак молочной железы и беременность. В. кн.: Параконная А.А., ред. Рак и репродукция. М.: Общество онкологов-химиотерапевтов; 2011: 40-5.
  2. Снежко О.А. Рак молочной железы и беременность. Главный врач Юга России. 2018; 4: 49-51.
  3. Дашян Г.А., Семиглазов В.Ф., Семиглазов В.В., Топузов Э.Э., Криворотько П.В., Донских Р.В., Табагуа Т.Т., Гречухина И.А., Джукаева Ц.С. Диагностика и лечение рака молочной железы, развившегося на фоне беременности. Вопросы онкологии. 2011; 57(5): 584-91.
  4. Волочаева М.В., Шмаков Р.Г., Зубков В.В. Здоровье детей, рожденных женщинами с раком молочной железы, связанным с беременностью. Акушерство и гинекология. 2014; 7: 33-7.
  5. Тер-Ованесов М.Д., Шаль Е.П., Кукош М.Ю., Оганисян А.Н. Рак молочной железы, ассоциированный с беременностью: диагностика, лечение, прогноз. Медицинский алфавит. 2018; 29: 10-6.
  6. Azim H.A. Jr., Santoro L., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A. Prognosis of pregnancy-associated breast cancer: a metaanalyses of 30 studies. Cancer Treat. Rev. 2012; 38(7): 834-42. https://dx.doi.org/10.1016/j.ctrv.2012.06.004.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies